Wealth Enhancement Advisory Services LLC Increases Position in Corteva, Inc. $CTVA

Wealth Enhancement Advisory Services LLC raised its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 13.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 172,072 shares of the company’s stock after purchasing an additional 20,572 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Corteva were worth $12,154,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Norges Bank purchased a new position in Corteva during the second quarter valued at $434,220,000. Pacer Advisors Inc. increased its holdings in shares of Corteva by 4,007.1% during the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after acquiring an additional 2,382,715 shares in the last quarter. Amundi raised its position in shares of Corteva by 125.3% in the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after purchasing an additional 1,899,248 shares during the last quarter. Marshall Wace LLP grew its position in Corteva by 1,365.9% during the 2nd quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock valued at $134,882,000 after purchasing an additional 1,686,309 shares during the last quarter. Finally, Squarepoint Ops LLC raised its holdings in Corteva by 423.6% in the third quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock worth $117,550,000 after buying an additional 1,406,199 shares during the last quarter. 81.54% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CTVA shares. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Jefferies Financial Group increased their target price on Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, March 2nd. Wells Fargo & Company lifted their target price on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. UBS Group downgraded Corteva from a “buy” rating to a “hold” rating in a report on Monday, February 9th. Finally, CICC Research increased their price objective on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $82.90.

Insider Buying and Selling at Corteva

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.14% of the stock is owned by company insiders.

Corteva Trading Up 1.0%

NYSE:CTVA opened at $82.83 on Friday. The company has a market cap of $55.61 billion, a PE ratio of 52.42, a price-to-earnings-growth ratio of 2.80 and a beta of 0.72. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a 50 day simple moving average of $76.00 and a two-hundred day simple moving average of $69.62. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $82.89.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period last year, the business posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is presently 45.57%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.